A bill which Rep. Leo Berman (R-Dist. 6) has introduced for consideration by Texas’ 82nd Legislature would give a whole new meaning to the phrase, “Don’t Mess With Texas.” If HB 297 becomes law, the Lone Star State will be on a direct collision course with the federal government over Obamacare because it would criminalize any attempt to implement it in Texas.
A controversial “birth control” drug, approved by the Food and Drug Administration (FDA) despite evidence that it induces abortion in women who take it, is now on sale in the U.S. On December 1 Watson Pharmaceuticals, the New Jersey-based distributor of the drug known as “Ella,” announced that it is now available by prescription at pharmacies and clinics across the nation, as well as through some online pharmacies.
You win some; you lose some. In October, a federal judge in Michigan dismissed a lawsuit challenging ObamaCare’s individual mandate, arguing that Congress has the power to impose such a mandate under the Commerce Clause. A week later a federal judge in Florida permitted a similar lawsuit to proceed because he believed that the individual mandate stretched the Commerce Clause beyond the breaking point, saying that for him it “is not even a close call.” A Virginia federal judge had previously permitted another lawsuit to proceed on similar grounds.
In a November 20 New York Times story, Robert Pear writes: “Consumer advocates fear that the health care law could worsen some of the very problems it was meant to solve — by reducing competition, driving up costs and creating incentives for doctors and hospitals to stint on care.”